Referring clinicians

The Precision Care Clinic supports treating clinicians and their cancer patients to access our molecular multidisciplinary team (MDT) +/- patient consultation within the Australian public healthcare system.

Photo of medical doctor using digital healthcare

The purpose of the clinic is to provide guidance to resolve uncertainty or obtain clarification around targeted therapy options, or variants found (somatic or germline) and its consequence for subsequent management. It is intended to be of assistance in the primary clinician’s management plan.

How to refer

If you would like to refer your patient to the Precision Care Clinic, please use the following link:

An example of the form is below.

Patient flow

Precision Care Clinics Initiative Infographic - Patient flow Precision Care Clinics Initiative Infographic - Patient flow

Why refer?

Our service provides molecular multidisciplinary team support to facilitate discussions about a patient’s care within the framework of complex biomarker testing within the public system. This support may involve interpreting and reviewing molecular results on a case-by-case basis plus providing a forum for discussion and shared decision making amongst oncology, genetics, and other key precision care disciplines, to optimise evidence-based care.

Who to refer

    • Therapeutic advice and recommendations based on thorough evidence review and in-depth discussions within our molecular multidisciplinary team. 
    • Identifying potentially suitable local trials taking molecular profiling into account. 
    • Liaising with local and international experts to ensure up-to-date and evidence-based holistic case review. 
    • Patient consultation (in person or telehealth) with our medical oncology and/or cancer genetics team to support existing care with their local oncology team. 
    • Reviewing tumour profiling report to advise clinicians regarding any clinically meaningful, potentially inherited (germline) genes that may require further follow-up. 
    • Manage genetic testing of blood DNA for select potentially inherited (germline) very high utility genes (including but not limited to BRCA1/BRCA2). 
    • Facilitation of further molecular testing, including germline. 

    We accept Australia-wide referrals for patients who have received tumour molecular results and would benefit from further review or interpretation within the current clinical context. This includes considering genomically informed treatment options and assessing for hereditary cancer predisposition. The clinic is designed to support local clinicians and is not a treatment or a second opinion service.

Be involved

Contact us

P: 02 9382 5111
F: 02 9382 5180
E: precisioncareinitiative@unsw.edu.au

Visit us

Nelune Comprehensive Cancer Centre
Prince of Wales Hospital
Randwick NSW 2031